This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis
Clinical trial NCT02772601 · COMPLETED
Trial details
- NCT number
- NCT02772601
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-15
- Primary completion
- 2017-06-15
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.